Trial Profile
Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Inflammation
- Focus Therapeutic Use
- Acronyms TACTICAL-HIV
- 15 Aug 2019 Status changed from recruiting to completed.
- 23 Mar 2018 Planned End Date changed from 1 Sep 2018 to 1 Jan 2019.
- 23 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Dec 2018.